ENDO 2022 was once again a hotbed of new research as people convened in person and online from around the world. Here, we look at two international researchers who shared their COVID-19 studies in poster presentations that looked at the pandemic’s impact on thyroid function, thyroid dysfunction, and the impact on women’s ovulatory cycles. ENDO...
COVID-19 Pandemic Associated with Disruptions to Women’s Reproductive Health
Women’s reproductive health has been disrupted as a result of the psychological burden of the COVID-19 pandemic, and affected women need additional medical and psychological support, according to research presented at the Society for Endocrinology annual conference in Edinburgh last November. The findings indicate that stress and sleep disturbance related to the pandemic have had...
COVID-19 May Trigger Hyperglycemia and Worsen Disease by Harming Fat Cells
COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study in Cell Metabolism. Researchers led by James C. Lo, MD, PhD, an associate professor of medicine in the Weill Center for Metabolic Health and the Cardiovascular Research Institute at Weill Cornell Medicine and a cardiologist at NewYork-Presbyterian/Weill Cornell Medical Center, found that hyperglycemia is common in hospitalized COVID-19 patients and...
This week, Precision Diabetes, Inc. presented data demonstrating that the 1,5-anhydroglucitol blood test (GlycoMark®) is more accurate than commonly used diabetes tests in predicting mortality in hospitalized COVID-19 patients with and without diabetes. The study, “1,5-anhydroglucitol is an Independent Predictor of Mortality in Patients with COVID-19,” was presented at the American Heart Association (AHA) 2021 Scientific...
People Over 40 with Type 1 Diabetes and COVID-19 Are More Likely to be Hospitalized
Adults with type 1 diabetes need to be extra cautious of COVID-19 as they are more likely to be hospitalized and die, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. People with diabetes are at higher risk for COVID-19-related complications, especially if they are over the age of...
Kids in Lockdown: How COVID-19 Affected Children with Type 1 Diabetes
ENDO 2021 presented a plethora of research detailing how COVID-19 impacted a number of endocrine comorbidities. However, two studies in particular took a closer look at how the virus impacted pediatric patients with type 1 diabetes. Each year, ENDO is something of an “embarrassment of riches” because it consists of four days packed with the...
Over the Edge: Is COVID-19 Introducing a New Type of Diabetes?
Researchers are exploring the complex, push-pull relationship between COVID-19 and diabetes. Is the virus truly the cause of a new type of diabetes or is it merely hastening an inevitable development in susceptible patients? From the earliest days of the COVID-19 pandemic, its effects on glycemic control have been among its challenges. Patients with...
Proof-of-Concept Study Shows CGM Benefit in Patients with COVID-19
A proof-of-concept study recently published in Diabetes Care shows how inpatient diabetes technology is advancing and can provide meaningful improvements in care today and in a post-pandemic world. The research team, led by Francisco J. Pasquel, MD, MPH, assistant professor of medicine in the Division of Endocrinology at Emory University in Atlanta, write that point-of-care...
